Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

64Cu- DOTA,1-Nal(3)]-octreotide (DOTANOC) PET/CT in Neuroendocrine Tumors: Initial Experience in Single Centre in Mexico.

Francisco Garcia-Perez, Hector Valdovinos, Paulina Munguia, Irma Soldevilla-Gallardo, Sevastian Medina-Ornelas, Roberto Pedrero-Piedras, Filiberto Lemus and Joel Vargas-Ahumada
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 129;
Francisco Garcia-Perez
1Instituto Nacional de Cancerología Mexico City Mexico
2Pet/ct Imagenus - Diagnostics in Healthcare Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hector Valdovinos
1Instituto Nacional de Cancerología Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulina Munguia
1Instituto Nacional de Cancerología Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irma Soldevilla-Gallardo
1Instituto Nacional de Cancerología Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sevastian Medina-Ornelas
1Instituto Nacional de Cancerología Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Pedrero-Piedras
1Instituto Nacional de Cancerología Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filiberto Lemus
1Instituto Nacional de Cancerología Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Vargas-Ahumada
1Instituto Nacional de Cancerología Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
64Cu- DOTA,1-Nal(3)]-octreotide (DOTANOC) PET/CT in Neuroendocrine Tumors: Initial Experience in Single Centre in Mexico.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
64Cu- DOTA,1-Nal(3)]-octreotide (DOTANOC) PET/CT in Neuroendocrine Tumors: Initial Experience in Single Centre in Mexico.
Francisco Garcia-Perez, Hector Valdovinos, Paulina Munguia, Irma Soldevilla-Gallardo, Sevastian Medina-Ornelas, Roberto Pedrero-Piedras, Filiberto Lemus, Joel Vargas-Ahumada
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 129;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
64Cu- DOTA,1-Nal(3)]-octreotide (DOTANOC) PET/CT in Neuroendocrine Tumors: Initial Experience in Single Centre in Mexico.
Francisco Garcia-Perez, Hector Valdovinos, Paulina Munguia, Irma Soldevilla-Gallardo, Sevastian Medina-Ornelas, Roberto Pedrero-Piedras, Filiberto Lemus, Joel Vargas-Ahumada
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 129;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Simultaneous PET/MR reveals significant correlation between the intravoxel incoherent motion parameters and standardized uptake values in nasopharyngeal carcinoma patients
  • Accuracy of 18F-fluoroethyltyrosine PET for detecting high grade glioma recurrence: size matters
Show more Oncology: Clinical Therapy and Diagnosis

NET and Others II

  • An uptake time compliancy retrospective for a multi-center NCTN 18F-FDG PET/CT Clinical Trial
  • The value of 18F-FDG PET/MR whole body imaging in staging of pediatric neuroblastoma
  • Superiority of68Ga-DOTATATE PET/CT compared to18F-FDG PET/CT and MRI of the spine in the detection of spinal bone metastases in metastatic pheochromocytoma and/or paraganglioma
Show more NET and Others II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire